Public Joint-Stock Company "Pharmsynthez" (LIFE.ME)
RUB 4.51
(10.15%)
RUB 4.51
(10.15%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.35 Million | -62.69 Million | -232.76 Million | -96.59 Million | -15.48 Million | -137.46 Million |
| Net Income | -208.71 Million | -733.4 Million | -527.21 Million | -1.81 Billion | 59.76 Million | -2.84 Billion |
| Depreciation & Amortization | 27.5 Million | 31.95 Million | 44.39 Million | 25.92 Million | 54.59 Million | 50.68 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 95.38 Million | -11.42 Million | -23.31 Million | -49.37 Million | 319.13 Million | 623.31 Million |
| Other non-cash items | 82.46 Million | 650.17 Million | 273.36 Million | 1.73 Billion | -59.76 Million | 2.03 Billion |
| Investing Cash Flow | -4.47 Million | -1.9 Million | -9.68 Million | 22.82 Million | -350 Thousand | -21.86 Million |
| Investments in PPE | -3.47 Million | -279 Thousand | -9.68 Million | -14.5 Million | -19.35 Million | -24.26 Million |
| Acquisitions | - | - | - | - | - | -14.81 Million |
| Investment purchases | - | - | - | - | -350 Thousand | -53.09 Million |
| Sales/Maturities of investments | - | - | - | - | - | 54.51 Million |
| Other Investing Activities | -1 Million | -1.62 Million | - | 37.32 Million | - | 15.79 Million |
| Financing Cash Flow | -1.97 Million | 68.11 Million | 178.88 Million | 137.7 Million | -1.5 Million | 33.51 Million |
| Debt repayment | -26.87 Million | -20.01 Million | -12.76 Million | -4.65 Million | -1.5 Million | -33.51 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 23.73 Million | - | 87.26 Million | - | - | - |
| Other Financing Activities | 1.16 Million | 88.12 Million | 104.38 Million | 142.36 Million | 65.67 Million | 33.51 Million |
| Accounts receivables | 9855.00 | 15.76 Million | 74.09 Million | -57.19 Million | 93.06 Million | -90.57 Million |
| Accounts payables | -9855.00 | -36.81 Million | -105.09 Million | -109.92 Million | 232.76 Million | 69.18 Million |
| Inventory | -8.95 Million | 9.63 Million | 7.68 Million | 117.74 Million | -6.69 Million | -21.57 Million |
| Other working capital | 104.34 Million | -798.00 | -101.5 Million | -8744.00 | - | 644.88 Million |
| Cash at beginning of period | 15.29 Million | 10.41 Million | 66.92 Million | 233 Thousand | 3.95 Million | 378.59 Million |
| Cash at end of period | 9.17 Million | 15.29 Million | 10.41 Million | 64.31 Million | 233 Thousand | 326.67 Million |
| Capital Expenditure | -3.47 Million | -279 Thousand | -9.68 Million | -14.5 Million | -19.35 Million | -24.26 Million |
| Effect of forex changes on cash | 3.67 Million | 1.36 Million | 7.04 Million | 150 Thousand | 13.61 Million | 73.9 Million |
| Net cash flow / Change in cash | -6.12 Million | 4.88 Million | -56.51 Million | 64.08 Million | -3.72 Million | -51.91 Million |
| Free Cash Flow | -6.82 Million | -62.97 Million | -242.44 Million | -111.09 Million | -34.83 Million | -161.72 Million |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -81.8 Thousand | -81.8 Thousand | -208.71 Million | -70.02 Thousand | -70.02 Thousand | -67.44 Million |
| Depreciation & Amortization | 6124.00 | 6124.00 | 27.5 Million | 7896.00 | 7896.00 | 11.71 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -58.14 Thousand | -58.14 Thousand | 95.38 Million | 7950.00 | 7950.00 | 32.21 Million |
| Other non-cash items | -38.94 Thousand | -38.94 Thousand | 82.46 Million | 64 Thousand | 64 Thousand | -8.27 Million |
| Investing Cash Flow | -17.44 Thousand | -17.44 Thousand | -4.47 Million | -1318.00 | -1318.00 | -1.83 Million |
| Investments in PPE | -17.52 Thousand | -17.52 Thousand | -3.47 Million | -818.00 | -818.00 | -1.83 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 77.00 | 77.00 | -1 Million | -500.00 | -500.00 | - |
| Financing Cash Flow | 314.52 Thousand | 314.52 Thousand | -1.97 Million | -3587.00 | -3587.00 | 5.2 Million |
| Debt repayment | - | - | -26.87 Million | - | - | -5.2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 23.73 Million | - | - | - |
| Other Financing Activities | 314.52 Thousand | 314.52 Thousand | 1.16 Million | -3587.00 | -3587.00 | 2600.00 |
| Accounts receivables | -36.59 Thousand | -36.59 Thousand | 9855.00 | 22.04 Thousand | 22.04 Thousand | -34.22 Million |
| Accounts payables | - | - | -9855.00 | 0.50 | 0.50 | 59.87 Million |
| Inventory | -21.55 Thousand | -21.55 Thousand | -8.95 Million | -7761.00 | -7761.00 | 6.56 Million |
| Other working capital | - | - | 104.34 Million | -6330.50 | -6330.50 | - |
| Cash at beginning of period | - | - | 15.29 Million | 2.48 Million | 2484.00 | 15.29 Million |
| Cash at end of period | 123.94 Thousand | 123.94 Thousand | 9.17 Million | 2.48 Million | 3345.50 | 2.48 Million |
| Capital Expenditure | -17.52 Thousand | -17.52 Thousand | -3.47 Million | -818.00 | -818.00 | -1.83 Million |
| Effect of forex changes on cash | -353.00 | -353.00 | 3.67 Million | -1580.50 | -1580.50 | 3418.50 |
| Net cash flow / Change in cash | 123.94 Thousand | 123.94 Thousand | -6.12 Million | - | 861.50 | -12.81 Million |
| Free Cash Flow | -190.3 Thousand | -190.3 Thousand | -6.82 Million | 9013.00 | 9013.00 | -24.84 Million |
WFC-PC
ASG
300399
HMNF
0788
MON